Rating History for AMAG Pharmaceuticals (AMAG) by Baird
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/18/2013 | N/A | Upgrade | Outperform (Neutral) |
N/A (N/A) |
20.69 (13.75) |
-33.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/18/2013 | N/A | Upgrade | Outperform (Neutral) |
N/A (N/A) |
20.69 (13.75) |
-33.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||